Ovensa raises $1.38 mln from Anges Québec, Aligo Innovation
Canadian biotechnology startup Ovensa Inc has secured $1.38 million in follow-on financing. The round was backed by 22 members of angel organization Anges Québec, the affiliated Anges Québec Capital, and Aligo Innovation, a university research commercialization company. Founded in 2012, Aurora, Ontario's Ovensa develops technology with mucosal and brain-barrier crossing properties that can deliver medication to hard-to-reach parts of the body. It is mainly focused on oncology. Led by President and CEO Stéphane Gagné, the company plans to use the funds raised to further develop its platform.
15 September 2017•4 mins read
